Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transscleral diode laser photocoagulation in refractory glaucoma.

V Pucci1, G Marchini, E Pedrotti

  • 1Department of Neurologic Science and Vision, Eye Clinic, University of Verona, Italy. vincenzo.pucci@tiscalinet.it

Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|June 16, 2001
PubMed
Summary

Contact transscleral diode laser cyclophotocoagulation (DLPC) effectively lowers intra-ocular pressure (IOP) in refractory glaucoma patients. This treatment also reduces medication needs and is relatively safe, though multiple sessions may be required.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vitro</i> pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay.

Frontiers in pharmacology·2023
Same author

Spread of <i>Toxoplasma gondii</i> among animals and humans in Northern Italy: A retrospective analysis in a One-Health framework.

Food and waterborne parasitology·2023
Same author

Culture-free genotyping of Neisseria gonorrhoeae from urogenital samples in a high-density urban area in the North of Italy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19.

Human reproduction (Oxford, England)·2021
Same author

Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.

Current urology reports·2020
Same author

XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice.

Clinical ophthalmology (Auckland, N.Z.)·2018

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Innovation

Background:

  • Refractory glaucoma presents significant treatment challenges.
  • Medical and surgical options are often limited for these patients.

Purpose of the Study:

  • To evaluate the efficacy of contact transscleral diode laser cyclophotocoagulation (DLPC).
  • To assess the impact of DLPC on intra-ocular pressure (IOP) and visual acuity in refractory glaucoma.

Main Methods:

  • A cohort of 36 patients (37 eyes) with refractory glaucoma underwent DLPC.
  • Follow-up averaged 14 months, analyzing IOP, visual acuity, and complications.

Main Results:

  • Mean IOP decreased from 33.1 mmHg pre-treatment to 21 mmHg post-treatment.

Related Experiment Videos

  • Average glaucoma medications reduced from 4.4 to 2.4.
  • Visual acuity remained stable in 67.5% of eyes; no serious complications were reported.

    • Conclusions:

    • DLPC is an effective treatment for lowering IOP in refractory glaucoma.
    • The procedure reduces the need for antiglaucoma medications and is relatively safe.
    • Multiple DLPC treatments may be necessary for optimal IOP control.